← Back to Search

Other

QLS-101, 2.0% for Ocular Hypertension

Phase 2
Waitlist Available
Led By Sharon Freedman, M.D.
Research Sponsored by Qlaris Bio, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 days
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new treatment called QLS-101 for adolescents with Sturge-Weber Syndrome who have high eye pressure. The medicine is applied to both eyes every morning for about a month to help reduce the pressure.

Eligible Conditions
  • Ocular Hypertension
  • Sturge-Weber Syndrome
  • Glaucoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Ocular safety
Systemic safety
Secondary study objectives
Ocular hypotensive effectiveness

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: QLS-101, 2.0%Experimental Treatment1 Intervention
Qlaris' investigational product, QLS-101, 2.0% concentration, ocular administration (eye drop), given once daily in the morning to both eyes
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
QLS-101 ophthalmic solution, 2.0 %
2022
Completed Phase 2
~10

Find a Location

Who is running the clinical trial?

Qlaris Bio, Inc.Lead Sponsor
6 Previous Clinical Trials
285 Total Patients Enrolled
4 Trials studying Ocular Hypertension
195 Patients Enrolled for Ocular Hypertension
Sharon Freedman, M.D.Principal InvestigatorDuke Eye Center
~1 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top